Registration Options

Activity Dates: 04/24/2020 - 04/24/2023

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

CPNP members share their experiences dealing with clinical problems. Pearls include pre-exposure prophylaxis for HIV, bromism, and contaminants in CBD products.

Pre-Exposure Prophylaxis for HIV: A Primer for Psychiatric Pharmacists

Josh Brockbank, PharmD

Pre-exposure prophylaxis for HIV (PrEP) is highly effective at preventing new HIV infections. People with severe mental illness and people who inject drugs using shared equipment are at an increased risk of HIV acquisition. Mental health pharmacists are well-positioned to screen patients for high-risk behaviors, then appropriately educate and refer patients for PrEP.  This presentation will review indications for PrEP and provide tips on how to integrate brief screening into a psychiatric medication management appointment.

Unexpected Consequences of Medication Misuse: Robotripping into Bromism

Haley Pals, PharmD

While dextromethorphan misuse carries its own health risks, it is important to note the potential for patients to develop unexpected sequalae of drug misuse such as bromism. This clinical pearl will follow a case resembling common dextromethorphan misuse with psychotic features that persisted beyond a normal course of intoxication, uncovering an underlying diagnosis of bromism. The combination of confusion or psychosis, hyperchloremia, and low or negative anion gap in absence of other causative factors should refer clinicians to consider bromism in the differential diagnosis. Clinicians should regularly assess patients with known dextromethorphan misuse for signs or symptoms of bromism.

The Cannabis Analysis: Discussing Common Contaminants in Cannabidiol-Related Products

Chanese Hampton, PharmD

The use of cannabidiol (CBD) products continues to increase throughout the United States despite limited data on safety and regulation of the production process. Recent product test results show CBD products are often mislabeled or inaccurately advertised to consumers. Additionally, many production processes may lead to the unintentional and intentional addition of contaminants. Given the recent rise in use and unknown efficacy and safety of CBD, this presentation will explore recent literature and product testing on CBD contamination.

4:27-4:30 PM: Session Conclusion

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Josh Brockbank, PharmD
Haley Pals, PharmD
Chanese Hampton, PharmD

View biographical information and disclosures

Learning Objectives

Pre-Exposure Prophylaxis for HIV: A Primer for Psychiatric Pharmacists

  1. State which patients should be offered HIV pre-exposure prophylaxis (PrEP) therapy.
  2. List techniques used within a psychiatric medication management encounter to assess an individual's risk of acquiring HIV.

Unexpected Consequences of Medication Misuse: Robotripping into Bromism

  1. Recognize presenting characteristics of dextromethorphan intoxication and bromide toxicity.
  2. Select a treatment plan for treatment of bromism in a specific patient case.

The Cannabis Analysis: Discussing Common Contaminants in Cannabidiol-Related Products

  1. Recognize common contaminants found in cannabidiol (CBD)-related products during the cultivation, extraction, and packaging process.
  2. Explain methods and techniques for evaluating CBD-related products for contamination.

Continuing Education Credit and Disclosures

Activity Dates: 04/24/2020 - 04/24/2023
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-20-035-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.